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1. Introduction 
 
Cancer is a multi-step process resulting from 
the accumulation of irreversible and transmitta-
ble genetic aberrations together with the con-
current presence of epigenetic alterations in 
susceptible cells [1, 2]. These contain thou-
sands of mutations [3], show altered respon-
siveness to the microenvironment [4], may 
evade host immune responses [5], select and 
expand particular cancer cell phenotypes that 
metastasize and/or become resistant to chemo-
therapy [6]. Roughly 13.3 million new cancer 
cases and 7.9 million cancer deaths have oc-
curred worldwide in 2010, respectively. Be-
cause of population ageing, these numbers are 
projected to rise to 15,0 million new cases and 
9.0 million deaths in 2015 and 21.4 million 
new cases and 13.1 million deaths in 2030, 
respectively [7]. However, at least ~30% of all 
cancer cases and roughly ~40% of all cancer 
deaths should be potentially avoidable through 
primary prevention of common modifiable risk 
factors [8, 9] and by improving early detection 
and treatment of amenable cancers when there 
is still some chance of successful benefit [10]. 
The development of reliable and affordable 
technologies for the screening of individuals 
with cancer, or who are likely to develop it in the 
future, as well as for improving the early diagno-
sis of cancer and the prediction of treatment 
outcomes with the aim of maximizing cure and 
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reducing morbidity to the lowest possible level 
may be as important as prevention activities to 
reduce the incidence of cancer. Therefore, one 
of the main issues in cancer research is repre-
sented by the discovery and validation of new 
cancer biomarkers. 
 
A biomarker of cancer is any structural and/or 
functional entity that can be objectively meas-
ured such as genes, proteins, metabolites, ac-
tivities and intermediate pathways, morphol-
ogic, cytogenetic and cytokinetic parameters, as 
well as any specific physical trait or detectable 
change connected with a cancer disease in hu-
man individuals [11]. Different individual ana-
lytical methods assembled in multiplexed ge-
nomic [12], proteomic [13, 14], and/or cell line-
based platforms [15] have been developed and 
utilized for the discovery of new cancer bio-
markers. These platforms are often associated 
also with high resolution imaging tools such as 
different microscope techniques [16]. The gen-
eration of an ever-increasing amount of high-
throughput of data implies the analysis of large 
data sets by sophisticated algorithms and bioin-
formatics tools. These are utilized to identify 
individual markers of interest or to derive signa-
tures and/or patterns of many markers. There-
fore, analytical platforms are generally inte-
grated within computational biology and bioin-
formatics facilities that are necessary to ana-
lyze, associate and correlate large amounts of 
data obtained from different sources [17, 18]. 
Technologies and biomarkers must be tested 
and validated in pre-clinical cell and animal 
models before undergoing final evaluation and 
validation in clinical trials and definitively used 
in clinics [19, 20]. These steps are necessary to 
define the performances of each test (e.g. ana-
lytical variability, sensitivity, specificity, repro-
ducibility, and reliability of the measurements) 
and to obtain experimental evidence on the 
accuracy levels with respect to the suggested 
application (screening, diagnosis, prognosis, 
therapy follow up). The results of this multidisci-
plinary approach ultimately need to meet with 
the acceptance of final users, mainly oncolo-
gists and pathologists who will perform clinical 
trials. 
 
The evaluation and validation of a cancer target 
biomarker implies costly and lengthy processes, 
especially for tests that are proposed for cancer 
screening. An ideal test requires poor sample 
manipulation and it has to be possibly non-
invasive, highly sensitive, specific and reliable 
as well as affordable to reduce the costs of clini-
cal trials. Unfortunately, these characteristics do 
not properly fit different “…omics” platforms 
that still are too expensive, and/or scarcely reli-
able for screening applications. Hence a high 
demand for developing new and complementary 
easily available analytical methods. 
 
Advances in biophotonics – a combination of 
biology and photonics concerning with the gen-
eration, emission, transmission, modulation, 
signal processing, switching, amplification, de-
tection and sensing of light – have broken the 
resolution (lateral resolution) of conventional 
light microscopes. Resolutions at length scales 
of tens to hundreds of nanometers have been 
achieved, mostly in combination with fluores-
cence probes, allowing the localization of single 
molecules with nanometer precision and the 
imaging of many cellular processes taking place 
within these diffraction-limited distances [21]. It 
is expected that the applications of these tech-
nologies for imaging will be enable researcher in 
the elucidation of the dynamics of cell compo-
nents interactions within cancer cells allowing 
significant advances in understanding cancer 
pathophysiology as well as to influence cancer 
biomarker and anticancer drug discovery. The 
parallel improvements of technologies for high 
resolution imaging of cancer in vivo [22, 23] 
might facilitate the detection and/or imaging of 
the smallest possible number of cancer cells in 
solid tumours, ideally before the “angiogenic 
switch” [24]. Moreover, also the use of 
nanotechnology may help in achieving this goal 
[25] since most current techniques for in vivo 
molecular imaging still detect cancer at a stage 
in which the disease is too far advanced to be 
cured [26]. 
 
Since the middle of 20th century infrared (IR) 
spectroscopy coupled to microscopy (IR mi-
crospectroscopy) has been recognized as a non 
destructive, label free, and highly sensitive and 
specific analytical method with many potential 
useful applications in different fields of biomedi-
cal research and in particular cancer research 
[27-29]. Fourier transform (FT) infrared (IR) 
spectrometers were commercially introduced in 
1970. They were characterized by peculiar ana-
lytical performances that mainly consisted in 
the use of trace sample (down to 100 ng), high 
throughput measurements without sample de-
struction and with minimal sample preparation, 
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frequency precision and reproducibility, rapid-
scan analysis, and computerized data handling 
and storage. Their principal limitation was (and 
still is) the low spatial resolution at the focus 
point in the sample resulting in a measured 
sample area in the order of square millimeters. 
After various events, only in the 80’s the first 
commercial infrared microscope designed ex-
clusively for FT-IR spectrometers became avail-
able allowing to perform FT-IR microspectro-
scopy (microFT-IR). In the past three decades, 
many other technological improvements have 
been made to facilitate biomedical applications 
of microFT-IR extensively reviewed in [30] which 
has been successfully applied to samples from 
a variety of cell lines [31], blood cells [32, 33], 
and tissues [34] included cervix [35], breast 
[36, 37], prostate [38], lung [39], colon [40, 
41], brain [42-44], skin [45-47], esophagus 
[48], liver [49], lymph system [50, 51] and stem 
cells [52-56]. The results of all those studies 
have clearly indicated that microFT-IR associ-
ated with the use of some appropriate statisti-
cal data analysis methods [57] has an accuracy 
in classifying normal and malignant tissues/
cells in the order of 80-100%. In spite of its 
many advantages, the application of microFT-IR 
to cancer research and clinical diagnostics con-
tinues to be ‘under strong development’ or 
‘promising’ and to the best of our knowledge, no 
microFT-IR system has been put in clinical trials 
for cancer screening or diagnosis to date. On 
the contrary, it is long since applied in microbiol-
ogy where it allows the rapid and inexpensive 
characterization and classification of microor-
ganisms [58, 59]. This underuse of microFT-IR 
has been mainly ascribed to the difficulty of 
directly applying this technique in vivo, to its 
relatively low spatial resolution mostly confined 
to the micrometric scale as well as to a certain 
complexity in treating and interpreting data, a 
feature, however, that is shared with other ana-
lytical applications. Although recent technologi-
cal improvements [60] may represent new rea-
sons for hope to introduce microFT-IR spectros-
copy and imaging into clinics [61] one can also 
suspect that this powerful analytical technique 
has not yet properly come into the scientific 
background of many potential end users [62] 
and de facto it is mainly utilized for research 
scopes into Synchrotron Radiation (SR) infrared 
beamlines facilities. This poses the urgent de-
mand also for a more appropriate and general-
ized interdisciplinary scientific education as well 
as for more criticism that appears to be neces-
sary for the selection, identification and correct 
application of appropriate analytical methods in 
cancer research as well as in the diagnosis and 
follow-up of cancer diseases. 
 
This review is aimed at illustrating some princi-
ples of Fourier transform (FT) IR spectroscopy 
and microscopy (microFT-IR) to interrogate 
molecules in specimen by mid-IR radiation. It is 
not necessary to be a composer to enjoy vibra-
tions from a nocturne of Chopin. Likewise, it is 
not mandatory to be a physicist to be aware of 
phenomena that govern interactions between 
mid-IR radiation and matter. On the contrary, 
penetrating into basics of molecular vibrations 
might help us to understand whether, when and 
how complementary information obtained by IR 
vibrational spectroscopy and microscopy is use-
ful in our research and/or diagnostic activities. 
The implications of coupling FT-IR spectrometry 
with an IR microscope to perform microFT-IR, to 
obtain spatially resolved chemical images of an 
object, and to resolve the molecular structure 
and composition of a sample within a micromet-
ric scale in a matter of seconds will be also pre-
sented as well as some limitations of microFT-IR 
will be illustrated. Some examples of how bio-
chemical, structural, and dynamical information 
about the systems can be obtained by bench 
top microFT-IR instrumentation also when no 
fluorescent probe and/or specific biomarker is 
available will be also illustrated together with 
the principal techniques to obtain mid-IR spec-
tra and methods to treat and interpret IR spec-
tral data. The FT-IR absorbance spectrum is one 
of the most information-rich and concise way to 
represent the whole “…omics” of a cell and, as 
such, fits all the characteristics for the develop-
ment of a clinically useful biomarker. 
 
2. IR radiation and molecular vibrations 
 
Electromagnetic waves existing within a wide, 
continuous range of frequencies known as the 
electromagnetic spectrum have been exten-
sively used in cancer research and diagnosis. 
For instance, the highest energy photons associ-
ated with the shortest wavelength, λ, and with 
the highest frequency, ν, characterize X-rays 
and Gamma-rays. Opposite, the lowest energy 
photons, the longest wavelength, λ, and the 
lowest frequency, ν, characterize the region of 
radio waves that around 40-50 MHz are used in 
nuclear magnetic resonance (NMR) and mag-
netic resonance imaging (MRI). Infrared (IR) 
radiation spans an interval of electromagnetic 
spectrum between the red end of the visible 
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region (λ ~780 nm, ν ~0.38x1015 Hz, and hν 
~1.59 eV) and the beginning of microwaves 
region (λ = 1 mm, ν = 3x1011 Hz, and hν = 
1.24x10-3 eV). Within this IR interval three re-
gions of increasing wavelengths have been rec-
ognized: near-IR (λ from ~780 nm to 2.5 µm), 
mid-IR (λ from 2.5 µm 25 µm), and far-IR (λ 
from 25 µm to 1000 µm), respectively. The 
more convenient and the most commonly used 
spectroscopic unit in the IR region is the recipro-
cal of the wavelength, 1/λ, called wavenumber,  
, (the number of waves per unit length) with 
unit of reciprocal centimeter (cm-1). Wavenum-
ber,   , wavelength, λ, and frequency, ν, are re-
lated by the equations Eq. 1 and Eq. 2: 
 
Therefore, the IR region of the electromagnetic 
spectrum has dimension of wavenumbers ex-
tending from ~13000 cm-1 to ~10 cm-1, with 
near-IR, mid-IR, and far-IR regions spanning 
from ~13000 cm-1 to 4000 cm-1, from 4000 cm-
1 to 400 cm-1, and from 400 cm-1 to 10 cm-1 
wavenumbers, respectively. 
 
The range of energy photons in the mid-IR re-
gion extends between 0.05 eV and 0.5 eV. 
Since these energy values fit the quantized vi-
brational transitions of intra- and inter-
molecular bonds of bonded atoms in molecules, 
mid-IR photons can be absorbed by molecules 
that are in periodic (sinusoidal) motion 
(molecular vibrations). The frequency of vibra-
tion, ν, is related by the Hooke’s law to a force 
constant, f=-kΔr, which is proportional to the 
entity of displacement between the two atoms, 
Δr, and to the reduced mass, mr=m1m2/
(m1+m2) as illustrated in Figure 1a. The fre-
quency, ν, rises when the force constant, f, in-
creases, that is when the electron density in the 
bond between the two atoms increases, as ex-
emplified in the table of Figure 1b. On the con-
trary, frequency decreases with the increasing 
values of reduced mass, mr. The frequency of a 
vibration, ν, is inversely proportional to the 
atomic masses and directly proportional to the 
bond strength and therefore the vibrational 
mode of a chemical bond and/or a chemical 
group may occur at a specific frequency. 
IR absorbance vibrational spectroscopy 
 
When a sample matter, for instance a pure 
molecule, is placed in the path of an IR beam 
light between the source and the detector, the 
molecule will absorb only the frequency of mid-
IR that coincides with the frequency of the vibra-
tion allowing the molecule enters in a resonant 
vibration status. IR absorbance spectroscopy 
extensively treated in [63-65] measures the loss 
of IR radiation transmitted through a sample 
across an interval of frequencies of electromag-
netic spectrum. Depending on the selected in-
terval of wavelengths, near-IR spectroscopy, mid
-IR spectroscopy, and far-IR spectroscopy (THz 
spectroscopy) can be performed using near-IR 
radiation, mid-IR radiation, and far-IR radiation, 
respectively. Mid-IR absorbance spectroscopy 
plots the recorded intensity of absorption bands 
versus an interval of wavenumbers,     , from 
4000 to 400 cm-1, which corresponds to 
changes of vibrational energy levels from the 
ground level to the first energy level (E0→E1) in 
molecules. 
 
Fundamental vibrational modes (also called 
normal modes) that are detectable by mid-IR 
spectroscopy are mainly represented by bond 
stretching (either symmetric, νs, and antisym-
metric, νas) and bond deformations (mainly sym-
metric and antisymmetric bending, δs and, δas 
respectively; other vibrational modes are twist-
ing, γt, wagging, γw, rocking, γr, and scissoring 
motions. Fundamental vibrations concerning 
with water molecule are shown in Figure 1c. In a 
free H–O–H molecule the antisymmetric and 
symmetric stretching vibrations (νas and νs, re-
spectively) and the bending (δ) deformations of 
O–H group occur at ~3500 cm-1, ~1650 cm-1, 
and ~600 cm-1, respectively. Since the fre-
quency of a vibration is concurrently determined 
by the bond strength, the vibrational mode and 
the reduced mass, mr, of atoms composing 
chemical groups, the frequencies at which spe-
cific vibrations occur within the spectrum are 
fairly constant for a given functional group (e.g., 
–CH2, –C=O, O–H, etc.), as summarized in Table 
1. For instance, the stretch of methylene group, 
(νas CH2 and νs CH2), in molecules occur be-
tween ~2950 cm-1 and ~2860 cm-1, respec-
tively. As indicated in the harmonic oscillator 
model of Figure 1a, each of the two atoms (or 
groups) connected by the bond has an associ-
ated charge. If the two atoms are identical (e.g. 
O2, N2, etc.) and only one fundamental vibration 
 
Eq. 1 
Eq. 2 
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can occur, e.g. νs , there will be no net change 
of dipole moment during the vibrational transi-
tion and therefore there will be no detectable 
mid-IR activity. Therefore, also net change in the 
dipole moment must occur in the group mole-
cule in order for a particular vibrational mode to 
be detectable by mid-IR spectroscopy. For in-
stance, the planar CO2 molecule has no perma-
nent dipole moment, since the individual bond 
dipoles exactly cancel each other during sym-
metric stretching vibration (νs O–C–O) occurring 
at ~1480 cm-1. Nevertheless, the antisymmetric 
stretching, νas O–C–O at ~2560 cm-1 and the 
bending vibrations δ O–C–O at ~500 cm-1, re-
spectively can be detected because there is a 
net change in the dipole moment of CO2 mole-
cule at those wavenumbers allowing this mole-
cule becomes detectable by mid-IR radiation. 
Moreover, also the magnitude of the dipole mo-
ment change determines the intensity of ab-
sorption band. For instance, whereas the νC=O 
bands have strong absorbance values more 
symmetric vibrations such as νC=C have weaker 
absorbance values or even they are not absorb-
ing. 
 
A tri atomic, angular molecule like H2O produces 
3 normal vibration modes: one symmetrical, one 
asymmetric stretching vibration and a bending 
vibration (Figure 1c). In general, a polyatomic 
nonlinear molecule with N atoms has 3N–6 dis-
tinct vibrations (six results from three transla-
tional and three rotational movements of the 
whole molecule, respectively). In linear mole-
cules such as CO2, the number of possible vibra-
tions is 3N–5 (4 vibrational modes for CO2). For 
human albumin, a protein of 609 amino acids 
with > 9000 atoms, the number of possible vi-
brations results > 27000 if we assume an aver-
age of 15 atoms per amino acid [66]. Stretching 
vibrations of O2 and N2 as well as of many other 
non-IR active modes can be detected by Raman 
spectroscopy. Its principle of functioning is 
based on the selective inelastic scattering of a 
photon induced when a monochromatic radia-
tion (any excitation laser wavelength can be 
used) interacts with molecules that change their 
polarizability. A small fraction of light is scat-
tered by an excitation associated with vibra-
tional and rotational transitions of the molecule. 
The associated emerging photons of lower or of 
higher energy (frequency) can generate Stokes 
and anti-Stokes lines that in the Raman spec-
trum become detectable as shifts of frequency 
(Raman shifts) with respect to the incident ra-
diation. Also this complementary spectroscopic 
technique, that will be not described longer in 
this review, has many potential application in 
cancer research and diagnosis [67-69]. 
 
3. IR vibrational spectroscopy and microscopy 
 
All modern IR spectrometers use Fourier trans-
form (FT) and are composed of the following 
common elements: an internal IR light source, 
the interferometer (basically a Michelson inter-
ferometer), and a single element detector con-
nected with an amplifier and a computer [63]. 
The internal IR light is generated by a broad-
band, polychromatic continuum, conventional 
thermal light source such as a heated silicon 
Figure 1. The basis of infrared (IR) vibrational absorb-
ance spectroscopy. a. The classical harmonic oscilla-
tor model. b. Some examples illustratint the relation-
ships among atomic masses, bond strength and a 
particular vibrational mode (stretching) of some 
chemical groups. c. Fundamental vibrational modes 
of a molecule of free water detectable at specific 
frequency values within the mid-IR region of the elec-
tromagnetic spectrum. 
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carbide rod (Globar). Destructive or constructive 
interferences between IR light and matter are 
generated in the interferometer which consists 
of a system of mirrors, a stationary mirror and a 
moving mirror, and a semireflective lens (the 
beamsplitter, usually made of KBr). These inter-
ferences are recorded by the detector as a sinu-
soidal variation of intensity (cosine function) to 
the optical retardation which is Fourier trans-
formed (FT) to a spectrum (intensity as 
function wavenumbers,                       . For a mono-
chromatic radiation this results in a single line 
(band). With a broadband source 
(polychromatic, continuum source), constructive 
and destructive interferences in the spectral 
domain transmitted to and recorded by the de-
tector will generate an interferogram. This repre-
sents the summation of all the cosine functions 
of all the individual wavelengths present in the 
source and zero path difference (ZPD) positions 
where all interferences will be in phase (the 
centre-burst). The application of mathematical 
function Fourier transform will convert this inte-
ferogram into a mid-IR single-beam spectrum 
where the number of peaks will reflect the num-
ber of detectable components in the sample. 
The intensity in peaks, reflecting the amount of 
different molecular bonds absorbing in specific 
regions of the IR spectrum, will be in relation 
with the relative abundance of different sample 
constituents. The minimum wavenumber differ-
ence that can be distinguished between two 
lines in a spectrum corresponds to spectral 
resolution [64].  
 
FT-IR absorbance spectroscopy without a micro-
scope has absent or very limited spatial resolu-
tion [70] and the sample spectrum limits to re-
flect the average biochemical and structural 
information referred to the whole probed sam-
ple. The addition of an FT-IR microscope to the 
IR spectrometer has realized the possibility to 
detect vibrational motions of molecules within 
very restricted regions of the sample allowing 
the development of microFT-IR spectroscopy. 
The schematic layout of a typical microFT-IR 
apparatus is shown in Figure 2. This apparatus 
is used to associate the optical image of se-
lected object, for instance an individual cell, 
with the corresponding IR spectrum or its 
chemical image. 
 
The FT-IR microscope is similar to visible light 
microscope but it does not employ glass refrac-
 
Figure 2. The schematic layout of 
components in an microFT-IR 
apparatus. The external IR beam 
is generally provided by Synchro-
tron Radiation and a dedicated 
beamline is required to extract IR 
light from the storage ring of a 
Synchrotron and to collimate IR 
light to the experimental area 
where the microFT-IR apparatus 
is usually located several meters 
from the exit port. The descrip-
tion of microFT-IR apparatus and 
the functioning of single compo-
nents are in the text. 
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tive elements (glass is opaque to IR light of λ> 
~5µm). For this reason microFT-IR performed in 
transmission (described in 3.1) requires that 
probing samples are deposited on optical win-
dows (e.g. ZnSe, CaF2, and BaF2 crystals) that 
do not absorb, or absorb very low mid-IR radia-
tion and have very high values of transmittance 
within a wide range of frequencies in the mid-IR 
region. Switching on the separate visible light 
source and associated optics, the IR micro-
scope works like a standard optical microscope 
allowing the sample can be inspected by eye-
piece. Several spot areas can be selected (and 
marked) moving the computerized precision XYZ 
sample stage. Digitalized images can be re-
corded by a Charged-Coupled Device (CCD) 
camera in order to associate the image of se-
lected object visualized in the Liquid Crystal 
Display (LCD) or on the computer screen with its 
corresponding FT-IR absorbance spectrum. 
 
IR microscopes make use of Schwartzschild 
objectives (typically a combination of concave 
and convex mirrors aligned about the optical 
axis direct the beamlight through a hole) with a 
numerical aperture (NA) of ~0.61. With the sam-
ple placed between the Schwartzschild objec-
tive and the condenser, the microscope works 
in the confocal configuration and generally a 
spatial resolution of ~λ/2 is obtained [71]. Ad-
justable aperture slits of IR opaque material 
(e.g. glass) allow to delimit selected spot areas 
from which IR signals will be acquired switching 
on IR light. 
 
The FT-IR microscope is generally equipped with 
a single channel highly sensitive mercury cad-
mium telluride (MCT) photoconductive detector 
cooled in liquid nitrogen. Through connections 
with an amplifier the detector transmits the in-
formation to the computer. In a typical IR experi-
ment the goal is to obtain reproducible spectra 
with an acceptable value of signal to noise ratio 
(S/N) as defined by the ratio of source power 
(SP) to the noise power (NP). To this scope, 
enough IR signal must be cumulated on the 
detector by performing a number of scans in 
continuous mode within the selected interval of 
wavenumbers (e.g. from 4000 cm-1 to 600 cm-1) 
at a selected scanner velocity (e.g 40 kHz). Re-
ducing the aperture slits of microscope, the flux 
of photons to the detector reduces as well as 
the value of S/N. Increasing the number of 
scans extends the acquisition time necessary to 
obtain each spectrum. In order to optimize the 
acquisition with a single element detector, the 
number of scans and the aperture sizes must 
be therefore balanced acting on the SP and/or 
on the NP terms of the following equation: S/N 
= SP/NP. Working with a conventional thermal 
source such as Globar, which emits mid-IR ra-
diation in a 360 degrees distribution, and with 
aperture sizes reduced to ~20µm x 20µm or 
less, the photon throughput towards the detec-
tor significantly reduces while the detector noise 
remains constant and the value of S/N is 
strongly decreased independently on the dura-
tion of acquisition. Moreover, working with aper-
ture sizes approaching the wavelength of mid-IR 
radiation (2.5 µm - 25 µm) the recorded spectra 
become increasingly distorted due to diffraction 
effects that give much more difficult the analy-
ses in the spectra and results interpretation. 
Therefore, to increase S/N values one possibil-
ity is to modify the source power, SP, that is to 
increase the brightness or IR light, for instance 
using external IR light source from Synchrotron 
Radiation (SR) [72]. Whereas for aperture val-
ues ≥40µm x 40µm there is no substantial ad-
vantage of using SR with respect to Globar, the 
highest brightness of SR IR source provides ad-
vantage over Globar for shorter aperture set-
tings (≤20µm x 20µm down to the diffraction 
limit of ~3µm x 3µm). This is mainly due to the 
fact that the flux of SR IR photons is not a limit-
ing factor during the acquisition of IR signals. In 
this situation, spatial resolution becomes dif-
fraction limited [73]. However, when the instru-
mental setup has been optimized, high quality 
spectra of individual cells with a diameter of 
~15 µm can be obtained also with the conven-
tional and more accessible source Globar, as 
shown in Figure 3a. The two mid-IR absorbance 
spectra have been obtained from the same indi-
vidual cell restricted within aperture slits of 
15µm x 15µm in sizes and alternatively illumi-
nated with the internal (Globar) and with the 
external SR IR sources at the B22 IR microspec-
troscopy end station of Diamond Light Source, 
respectively. Higher noise, reflecting the lower 
S/N value, can be observed in the second de-
rivative of the absorbance spectrum obtained 
with Globar with respect to SR IR spectrum. SR 
microFT-IR might be therefore considered as a 
powerful technique to obtain high quality refer-
ence spectra or to perform the raster scanning 
of single cells as illustrated in Figure 3b. How-
ever, the scope of this simple experiment was to 
demonstrate that microFT-IR analysis on individ-
ual cells can be performed also with a conven-
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tional IR source which is more advantageous 
and reliable for routine applications than SR IR 
microFT-IR absorbance spectroscopy. 
 
Recently, FT-IR microscopes equipped with a 
second multichannel Focal Plane Array (FPA) 
detector have become available [74]. FPA com-
poses of many basic units with a sandwich 
structure (pixel). Two MCT layers, one detecting 
photons and the other carrying out signal collec-
tion, multiplexing and signal amplification, are 
respectively fixed together through a soft, elec-
trical conducting material. Each pixel unit, which 
functions as a discrete MCT detector within the 
array, allows to record a full IR spectrum within 
the interval 4000-900 cm-1. For an 64x64 FPA 
detector (up to 256x256 pixel FPA detectors are 
currently available) there are 4096 pixel units 
with a spatial area sampled by each pixel unit of 
~1-7x1-7 µm2, depending on the objective mag-
nification. Although the possibility to perform 
microFT-IR with FPA and SR IR beamlight has 
been reported [75] microFT-IR with FPA is typi-
cally carried out with bench top instrumenta-
tions using the more available conventional in-
ternal Globar source in a routine lab. No aper-
ture is set with FPA and the single pixel element 
defines spatial resolution. As compared to the 
single-point mapping approach which requires 
acquisition time in the timescale of hours, FPA 
detectors have dramatically improved the rate 
at which chemical information can be collected 
[76] allowing to generate microFT-IR absorb-
ance spectra and images in the timescale of 
minutes. Rather the problem working with FPA 
is the extremely large volumes of data gener-
ated and associated with chemical images (in 
the order of gigabytes of data per hour). Chemi-
cal images, or spectral “hypercubes”, obtained 
by FPA consist of pixel coordinates, wavelength, 
and intensity information. The analyses within 
such spectral “hypecubes” may reveal informa-
tion on the tissue architecture allowing for in-
stance to distinguish between normal and tu-
mor vasculature and to help the delimitation of 
areas in corresponding tissues [42]. 
 
MicroFT-IR techniques and samples 
 
With a single channel MCT detector microFT-IR 
analysis can be performed by one of the three 
following techniques: transmission, transflection 
which associates absorption with reflection, and 
attenuated total reflection (ATR). All three tech-
niques are aimed at obtaining IR spectra of high 
quality in representative samples. 
 
Transmittance represents the traditional means 
of measuring the mid-IR spectrum of a sample 
placed on an IR transparent substrate into the 
path of the IR beam light between the objective 
and the condenser of an FT-IR microscope. The 
intensity of mid-IR radiation passing through the 
sample, I , and reaching the detector is com-
pared to the intensity of mid-IR radiation reach-
ing the detector in the absence of the sample, I0 
(reference background spectrum). The resulting 
percentage of radiation transmitted, %T, by the 
pure sample substance at a given wavenumber, 
can be expressed as (Eq. 3): 
 
The transmittance, T, of the sample at a particu-
lar wavenumber,  , is given by a n d 
has values between 0 and 1. The lower the 
value of transmittance, T, and the more mid-IR 
radiation is absorbed through the sample of 
thickness (pathlength), I (in cm). 
 
The corresponding amount of mid-IR radiation 
absorbed, A, by the pure sample substance at              
is expressed as (Eq.4): 
where A is the absorbance. The Beer’s Law ex-
pressed by the following equation (Eq. 5): 
           
Relate the absorptivity of a pure substance, 
at a wavenumber, , in the mid-IR to the con-
centration of the sample, c, and to the relative 
number of absorbing molecules, Ic. Therefore, 
using a calibration procedure quantitative infor-
mation on sample components can be obtained 
by microFT-IR [75]. 
 
Information that can be obtained may concern 
 
Eq. 3 
 
  Eq. 4 
 
Eq. 5 
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with the variations of a single compo-
nent, for instance as a consequence 
of dynamic changes occurring during 
a biochemical reaction [77] or re-
flecting the different biochemical 
composition within samples of differ-
ent tissues and body fluids or among 
specimen from different individuals, 
as well as variations of many spec-
tral components associated, for in-
stance with the presence of onco-
genic viruses [78, 79] , different 
states of cancer aggressiveness [80] 
and/or the different sensitivity to 
anticancer drugs [81, 82]. 
 
As in any other experimental design, 
also in microFT-IR analysis sample 
preparation represents an important 
aspect to obtain qualitative and 
quantitative information on samples. 
However, as compared to other ana-
lytical techniques micro-FT-IR does 
not require extended sample ma-
nipulations. The major technical 
problem is water which strongly ab-
sorbs mid-IR light masking vibra-
tional absorption of other important 
molecules such as proteins, lipids, 
amino acids, carbohydrates, and 
other molecules within the sample 
[83]. Therefore, although <10 μm of 
bulk water can be acceptable since it 
can be subtracted in spectra by a 
Figure 3. Fourier transform infrared microspectroscopy (microFT-IR) on individual cell. a. The FT-IR absorbance spec-
trum of an individual human formalin-fixed and air-dried monocyte deposited on ZnSe window within the sampling 
interval of wavenumbers 3750-800 cm-1. The selected cell (36x magnification) was restricted by slits within a 15 µm 
x 15 µm sample area. This was alternatively illuminated with IR light from a broadband internal source (Globar, blue 
trace) and with beam of IR light from Synchrotron Radiation (SR, red trace) focused on the sample, respectively. To 
obtain acceptable signal to noise ratio (S/N) values a number of 128 scans was cumulated (velocity 20 kHz, spectral 
resolution 4 cm-1, total acquisition time 60 s) on a nitrogen cooled single element MCT detector with a detecting area 
of 50 x 50 μm2. The background (ZnSe) spectrum was collected from a 15 µm x 15 µm area external to the sample. 
Atmosphere water vapour and CO2 were compensated and the baseline was corrected using appropriate algorithms 
in the software. The superimposed second derivative spectra have been calculated by a generalized Savitzky-Golay 
smoothing algorithm on 9 points. The contribution of sub-bands in the markers peaks of amide I and amide II within 
the interval 1690-1480 cm-1 of SR IR spectrum has been highlighted in the framed box. b. The mapping of an individ-
ual formalin-fixed and air-dried cell by SR microFT-IR. The selected area was raster-scanned by collecting a series of 
spectra from 18x15 points grid (10 µm x 10 µm area, 2 µm step, 256 scans within the interval 4000-600 cm-1, scan-
ner velocity 20 kHz, spectral sensitivity 8 cm-1, one background area every five sample spectra) on a single channel 
100 µm x 100 µm MCT detector. The spectra were assembled and integrals were calculated within the interval of 
wavenumbers between 3000 and 2800 cm-1 (symmetric and antisymmetric stretching of CH3 and CH2 groups in lipid 
molecules) and between 1690 and 1480 cm-1 (amide I and amide II modes in proteins), allowing to obtain the two 
dimensional distribution of lipid and proteins, respectively. The intensity scale of false colors extends from the lowest 
absorbance (blue) to the highest absorbance (red-violet) values in the two dimensional contour maps superimposed 
to the underlying object, respectively. 
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software algorithm, microFT-IR is preferentially 
carried out on dried samples. The rapid dehy-
dration or formalin fixation can be performed to 
remove water from hydrated cells and tissues 
with no or minimal effects on the mid-IR spec-
trum [84]. Cells from cell cultures can be depos-
ited by the simple drop method or can be spun 
on the appropriate substrates where they are air
-dried. It is worth of note that the mid-IR spectra 
of hydrated cells grown in adherence on bio-
compatible and IR transparent substrates have 
been already described [85-87] and that the 
development of appropriate microfluidic devices 
might allow to investigate dynamical processes 
also in living cells [83, 88]. 
 
Sample thickness, the material dispersion on 
the substrate (cells, portions of cells) and the 
intrinsic homogeneity of biochemical compo-
nents within cells and tissue samples can influ-
ence the absorption spectra [89]. Since the 
measured absorbance, A, follows the Beer’s 
Law, samples thickness, I, might be between 3 
and 10µm in order to obtain intensities of ab-
sorbance in peaks that are distinguishable from 
the background noise in very thin samples as 
well as to avoid the saturation of some bands in 
thicker samples. An ideal sample has a flat sur-
face with a constant sample thickness within 
the probing area so that the non absorbed IR 
light that emerges from the sample and reaches 
the detector results parallel to the incident light. 
However, by some computational approach dif-
ferent thickness within sample and among sam-
ples (different optical pathlengths, I) can be 
minimized to compare the intensity of absorb-
ance in marker peaks. 
 
MicroFT-IR with single detector should be prefer-
entially performed selecting several probing 
areas (e.g. 50µm x 50µm with 36 x magnifica-
tion) on the most homogeneous zones of the 
sample. Also an individual cell is a heterogene-
ous object which can changes its shape and 
composition, for instance during its differentia-
tion [90-92], within the phases of cell cycle [93, 
94], as a consequence of changes in the culture 
medium [95] or during the induction of cell 
death by physical, chemical or drug agents [51, 
96-102]. Curiously, relatively large, dense 
patches of chromatin can block IR light from 
passing in some locations allowing unexpected 
reduced absorbance of DNA as an artifact in the 
spectrum of cells [103]. Moreover, IR light pass-
ing through cells can be deviated from its origi-
nal path and this scattering effect becomes evi-
dent in the mid-IR spectra of single cells pre-
senting broad oscillating baselines, shifted peak 
positions and distorted peak shapes [104]. This 
scattering effect has been attributed to signifi-
cant losses of mid-IR light with wavelengths 
fitting the sizes of a cell and/or of its intracellu-
lar components. For instance, the nucleus may 
result in resonant scattering (Mie scattering) 
[105]. Distortions due to resonant Mie scatter-
ing can be corrected using an appropriate algo-
rithm [106]. 
 
Transflectance (Figure 4) couples absorption 
and reflection through the sample [107]. It real-
izes when cells and tissues are lied on a glass 
slide coated with a thin layer of silver (low-e mi-
croscope slide) which makes the slide almost 
completely reflective to mid-IR radiation while it 
still remains totally transparent to visible light. 
Therefore, the sample can be inspected by visi-
ble light in transmission, whereas mid-IR radia-
tion passes through the sample, is reflected 
back by the coating on the low-e slide and then 
passing through the sample again directs to the 
detector. The resulting mid-IR spectrum is 
closely equivalent to a mid-IR transmission 
spectrum recorded from a sample of double the 
section thickness. This convenient method to 
obtain representative spectra of individual cells 
can be strongly affected by severe distortions 
associated with resonant Mie scattering. There-
fore, spectra necessitate to be always corrected 
for Mie scattering before applying algorithms for 
the classification of spectra [108]. Principal 
advantages of transflection microFT-IR are that 
low-e microscope slides are inert and therefore 
suitable for cell culture, resist to high tempera-
tures and therefore can be sterilized and re-
used, and are less costly than other biocompati-
ble substrates such as CaF2 and BaF2. 
 
Attenuated Total Reflectance (ATR) (Figure 4) is 
an internal reflection technique where the IR 
beam is directed through an internal reflection 
element (IRE) with higher refractive index, n1, to 
the sample with a lower refractive index, n2. The 
IRE element has the shape of a prism (or other 
geometric shape) and the crystal (ATR crystal) 
mounted in ATR objectives can be ZnSe or type 
IIa diamond (n1 = 2.4), or Si (n1 = 3.42), or Ge 
(n1= 4). This spectroscopic technique does not 
require a thin sample section is prepared and 
generates the mid-IR spectrum of the surface of 
probing sample placed into intimate contact 
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with the IRE element of ATR objective and can 
be utilize also in experiments with wet samples 
such as living cells [83]. Mid-IR radiation pass-
ing through the IRE will be totally internally re-
flected at the boundary separating the two me-
dia with n1 > n2 as well as it will provide an eva-
nescent wave (decaying wave) that penetrates 
the surface of the sample with n2  at an incident 
angle, i, that is greater than the critical angle, ic. 
As a consequence, this evanescent wave will be 
attenuated by the mid-IR absorption character-
istic of the lower refractive index medium and 
will provide IR data about sample composition 
[109]. The depth of penetration, dp, of evanes-
cent wave has direct dependence on wave-
length, λ, so that the depth of surface layer 
probed increases with increasing λ. A procedure 
called ATR correction [64] allows generating a 
spectrum in which the relative intensity of 
bands can be corrected allowing the ATR spec-
trum becomes very similar to an IR spectrum 
recorded in transmission. 
 
As for near-IR also mid-IR light can be coupled 
out of the spectrometer using silver halide 
(AgClBr) fiber optics that work as ATR elements 
[110]. Evanescent Wave Spectroscopy (EWS) is 
a new biophotonic technique based on the use 
of fiber optics in combination with IR spectros-
copy. This very promising spectroscopic tech-
nique has many potential applications in pre-
clinical and clinical cancer research and seems 
to realize the possibility to move IR spectros-
copy and microscopy “from the bench to the 
bedside” [40, 111]. 
 
Analyses in the spectra 
 
There are several different methods to ap-
proach the analysis of mid-IR spectra: from the 
simple inspection to identify the number of 
peaks to “chemometrics” where mathematical, 
statistical, and computer sciences methods are 
applied to improve the understanding of chemi-
cal information contained in typically broad and 
complex IR spectroscopic data [112]. Patterns 
in the data can be identified, modeled and must 
undergo independent validation [113] to be 
applied in probabilistic neural networks [114] 
useful for pre-clinical and clinical trials. It is the 
availability of validated models obtained by in-
terdisciplinary approaches that may represent 
the actual limitation for the application of mi-
croFT-IR spectroscopy in pre-clinical and clinical 
trials on cancer. 
 
Pre-processing (data set pre-processing) is re-
quired in order to reduce and correct interfer-
ences that may generate irrelevant variances 
such as atmospheric water vapour and carbon 
dioxide, variable background absorption pro-
files, and differences in sample thickness. Back-
ground intensity changes along the interval of 
wavenumebers that may alter the baseline are 
usually compensated by appropriate software 
methods for baseline correction (e.g.: Rubber-
band correction). However, baseline effects are 
almost completely removed and spectra with a 
mostly flat baseline are obtained also when the 
second derivative of an absorbance spectrum is 
calculated allowing, for instance to directly com-
pare the spectra of individual eukaryotic cells. A 
number of specific software procedures are 
available to reduce variances related to the dif-
ferent pathlength in samples and normalize 
data sets. The choice of normalization is in gen-
eral as crucial as the choice of the analysis 
technique itself. Rescaling the data, normaliza-
tion makes different variables and different 
Figure 4. Transflectance and Attenuated Total Reflec-
tance (ATR) techniques. 
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samples comparable allowing integrating them 
in a joint analysis. 
 
The simple inspection of the mid-IR spectrum of 
a cell, for instance that of a human monocyte 
shown in Figure 3a, identifies the presence of 
some peaks. The identification and assignment 
of spectral components (marker peaks) is gen-
erally performed by the so-called “group fre-
quency approach”. This represents a traditional 
 
Table 1. A summary of the vibrational frequencies of some functional groups in molecules within the mid
-IR region of electromagnetic spectrum 
Wavenumber 
(cm-1) 
Functional 
group 
Vibrational 
mode 
Commonly assigned biochemical 
component 
3500 - 2500 X-H stretching vibrations (where X is C, O, or N) 
~3300 N–H ν(N–H) Amide A: peptide, protein 
~3100 N–H ν(N–H) Amide B: peptide, protein 
2957 C–CH3 νas(CH3) 
lipids 
2920 –(CH2)n– νas(CH2) 
2872 C–CH3 νs(CH3) 
2851 –(CH2)n– νs(CH2) 
2000 - 1500 fundamental stretching vibrations of double bonds (e.g., C=O, C=C, C=N) 
~1740 –CH2–COOR ν(C=O) Phospholipid esters 
~1655 O=C–N–H 80% ν(CO), 20% ν(CN) Amide I peptide, protein 
~1645 H–O–H γ(HOH) Water 
~1545 O=C–N–H 60% γ(N–H), 30% ν(C–N), 10% ν(C–C) Amide II peptide, protein 
~1500 - 600 the “fingerprinting region”: many overlapped vibrations 
~1450  –(CH3)n– –(CH2)n 
δas(CH3) 
δas(CH3) Lipid, protein 
~1395 
–(CH3)n– 
–(CH2)n 
–O–C=O 
δs(CH3) 
δs(CH3) 
ν(C=O) 
Lipid, protein 
~1380 C–CH3 γs(CH3) Phospholipid, fatty acid, triglyceride 
1400 - 1200 O=C–N–H, CH3 
γ(N–H), ν(C–N), γ(C=O), ν(C–C) 
and ν(CH3) Amide III peptide, protein, collagen 
~1245 - 1230 RO–PO2––OR νas(PO2–) DNA, RNA, phospholipid, phos-phorylated protein 
~1170 R–COO–R’ νas(C–O) Ester 
~1160 and ~1120   ν(C–O) RNA ribose 
~1150 C–O, C–O–H ν(CO), γ(COH) carbohydrates 
~1095, ~1084, 
~1070 RO–PO2
––OR νs(PO2–) DNA, RNA, phospholipid, phos-phorylated protein 
~1078 C–C ν(CC) glycogen 
~1060, 1050, 1015 C–O ν(CO) DNA and RNA ribose 
~1050 C–O–P ν(COP) Phosphate ester 
~1028 C–O–H def(CHO) glycogen 
~965 PO32- ν(PO32-) DNA and RNA ribose 
~950 P–O ν(PO32-) Phosphorylated protein 
~920 C–O–P ν(COP) Phosphorylated protein 
ν, stretching; δ, bending; γ, wagging, twisting, and rocking; def, deformation, as, antisymmetric; s, symmetric. 
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and still very popular method of spectral analy-
sis. Frequency of vibration of specific functional 
groups is pre-assigned according to those ob-
served in the mid-IR spectrum of corresponding 
pure biomolecules [115] or of mixtures of mole-
cules [116] and compared with those already 
reported in the literature [117] and summarized 
in Table 1. However, much of the available infor-
mation is purely explorative and has limited util-
ity if not accompanied by an independent vali-
dation which appears of crucial importance to 
extend the number of potential applications of 
microFT-IR spectroscopy in cancer research and 
clinical diagnosis. 
 
The characteristic features of a mid-IR absorb-
ance spectrum of a cell are shown in Figure 3a. 
Major marker peaks are the Amide I and Amide 
II characterizing the spectrum of proteins and 
polypeptides. Amide I band absorbing at ~1650 
cm-1 identifies the C=O stretching mode, νC=O, 
associated with vibrations of a secondary am-
ide, –C(=O)N(H)–, whereas Amide II band ab-
sorbing at ~1550 cm-1 refers to the combination 
of both N–H bending and C–N stretching vibra-
tions. Not only Amide I and Amide II identify pro-
tein molecule but their positions and shapes 
may reflect changes in the secondary protein 
structure [66]. Moreover, νasCH3 and νasCH2 
observed at ~2958 cm-1 and at ~2920 cm-1 
together with the νsCH3 and νsCH2 occurring at 
~2872 cm-1 and at ~2852 cm-1, respectively 
identify lipid molecules. The νas and νsPO2- 
stretching vibrations occurring at ~1240 cm-1 
and at ~1085 cm-1 respectively can suggest the 
absorption of O–P=O linkages of the polynucleo-
tide chains in DNA and RNA. The identification 
and assignment of major spectral components 
by "functional group analysis" is particularly use-
ful for the qualitative analysis of pure organic 
molecules since the IR spectrum of each mole-
cule is unique and it can serve as a signature to 
distinguish among different molecules, for in-
stance pure proteins, nucleic acids DNA and 
RNA, lipids, and sugars. However, it is evident 
from Table 1 that the IR spectrum of a cell usu-
ally contains a large number or bands, many of 
which will be impossible to confidently assign to 
vibration of a particular group, in particular ana-
lyzing the so called “fingerprinting region”. 
Moreover, cell composes of many mid-IR active 
molecular constituents such as membrane lip-
ids and phospholipids, glycolipids, proteins, gly-
coproteins, phosphoproteins, nucleic acids DNA 
and RNA, carbohydrates and a variety of small 
metabolites that may concur to spectral fea-
tures. Therefore, we must conclude that the 
unequivocal interpretation of pre-assigned vi-
brational frequencies is impossible because the 
vibrations of different molecular components of 
a cell may overlap and the spectrum may reflect 
only the average biochemical composition. 
 
The fact that more than one vibrational mode 
may concur in peaks requires the application of 
some type of “resolution enhancement” such as 
derivative spectroscopy (e.g. second-derivative) 
together with some de-noising filter (e.g.: 
smoothing) [64]. The analysis of derivative spec-
tra is generally applied to identify the number of 
sub-band components that contribute within the 
peaks (Figure 3a). Generally sub-bands compo-
nents below the spectral resolution are not con-
sidered. Fourier self-deconvolution (FSD) is an-
other procedure that can be applied in an at-
tempt to separate overlapping bands into single 
sub-bands that are broader than spectral reso-
lution [118, 119]. However, the importance to 
obtain the highest S/N values becomes well 
evident comparing the second derivative spec-
tra of Figure 3a. Both spectra have acceptable 
S/N values but there is much more uncertainty 
in the identification and assignment of sub-
components in the second derivative spectrum 
obtained with Globar than in the spectrum ob-
tained with SR IR microFT-IR. Therefore the ap-
plication of algorithms for self-deconvolution 
could erroneously identify a high number of sub-
components. 
 
The calculation of difference spectrum is an-
other way to obtain information on biochemical, 
functional, structural and dynamical changes 
occurring also in complex samples and in some 
circumstances to identify spectral components 
that may assume the significance of IR bio-
markers [90]. For instance, during a typical time
-course or dose-response experiment with cells, 
the vibrations from groups that do not change 
during the stimulation annihilated each other, 
and only the changes occurring as a conse-
quence of the activation/inhibition become evi-
dent in the difference spectrum. 
 
Two-dimensional IR correlation spectroscopy 
[120] is a perturbation-based method that 
monitors the perturbation-induced changes 
caused by the application of a stimulus at each 
wavenumber by microFT-IR. When an external 
perturbation (e.g.: an agonist or an inhibitor) is 
applied, the overall response of the stimulated 
system (e.g.: cell culture) to the applied pertur-
Molecular vibrations in cancer research 
 
 
14                                                                                                                     Am J Cancer Res 2012;2(1):1-21 
bation leads to distinctive intensity changes, 
band shifts, and changes in band shapes in the 
measured spectrum. A data set of so-called dy-
namic spectra are generated (e.g. within time 
but also concentration, temperature, etc. can be 
considered) and compositional changes can be 
probed, for instance over the course of time, t, 
on time scales ranging from a few milliseconds 
to hours, depending on the specific microFT-IR 
setup. By a correlation method the set of IR 
spectra are correlated (synchronous, asynchro-
nous or other types of correlations) and a 2D 
cross-correlated spectrum is generated. In the 
2D correlation spectrum the intensity of spectral 
changes at each frequency are plotted as a 
function of two independent frequency axes (Z 
and X) over the third dimension time, allowing 
the complex spectra can be visualized in the 
simplified form of fishnet and/or contour map. 
By this method of representing IR data many 
overlapped peaks are better resolved. 
 
The different components identified within a 
spectrum can be quantified and compared 
among samples by univariate statistics. Since 
this limits to analyze individual components 
separately, it is not properly suitable for com-
parisons among large data set. Therefore the 
time-consuming univariate analysis is scarcely 
reliable for screening purposes. On the contrary, 
computer-based spectral analysis provides an 
objective method of scoring spectral informa-
tion independently of subjective manual inter-
pretation and therefore it may be potentially 
more sensitive, more consistent, and more ac-
curate [121]. To analyze data sets of complex 
biological matrices such as cells and tissues 
powerful algorithms of multivariate statistical 
analysis can be applied [122]. 
 
Multivariate pattern recognition methods com-
pare a large number of variables (e.g. absolute 
and relative intensity, the position, and the 
width of one or more absorptions) within a data 
set. In particular, multivariate classification with 
supervised or unsupervised pattern recognition 
can be applied. In supervised pattern recogni-
tion a substantial amount of information (e.g. 
biochemical or clinical data), is available regard-
ing the data set (e.g.. which sample belongs to 
drug treated class or untreated control class, 
which cellular phenotype has been considered 
within a cancer cell line, etc.). In unsupervised 
pattern recognition no “a priori” knowledge 
about the data set is required (e.g.: the class 
membership) and the computer system groups 
or clusters the data by using a set of general 
rules [123]. The most popular techniques are 
Principal Component Analysis (PCA) and Cluster 
Analysis (CA). PCA is a non-parametric method 
for extracting relevant information from confus-
ing data sets allowing to identify patterns in 
data and to highlight their similarities and differ-
ences [121]. PCA reduces the dimensionality, 
the number of variables of the data, by main-
taining as much variance as possible [124]. 
Major benefit of PCA is that the large number of 
initial variables are condensed to only a few 
variables (the so called principal component), 
those reflecting the most relevant analytical 
information [125]. Hierarchical Cluster Analysis 
(HCA) follows a bottom-up strategy to discover 
unexpected clusters that may not be initially 
evident. It begins with each element (whole 
spectrum or selected intervals of frequencies) 
as a separate cluster and then finds clusters in 
a series of partitions on the basis of succes-
sively established clusters. An example of the 
unsupervised recognition of pattern is illus-
trated in Figure 5. Initially, the mid-IR spectra 
are pre-processed, for instance with vector nor-
malization and second derivative. Then Euclid-
ean distances among the comparable spectra 
are calculated by a standard method. Euclidean 
distance is a descriptor of the degree of similar-
ity among two spectra or two clusters: the better 
two spectra (or clusters) match, the smaller the 
spectral distance. Finally, an algorithm usually 
performs the clustering process. For instance, 
Ward’s algorithm has been applied to obtain 
cluster distances shown in the dendrogram of 
Figure 5a. Instead of determining the spectral 
distance, this algorithm tries to find as homoge-
neous groups as possible merging only the two 
groups with the smallest growth in heterogene-
ity factor, H. At the end, only two groups are re-
mained, for instance viable (G0-G1 phase) and 
apoptotic cells whose average spectra are 
shown in Figure 5b, respectively. This technique 
does not require assumption to be made about 
the number of data groups and has assumed 
great popularity, for instance to classify bacteria 
[58] and eukaryotic cells [57], mostly due to its 
simplicity and ease of interpretation. 
 
Other than in histopathology other application of 
microFT-IR might include evaluation of drug effi-
cacy in both cellular models used for drug 
screening or primary cells obtained from individ-
ual patients. In line with these possibilities we 
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could associate a specific region of mid-IR ab-
sorbance spectrum to the reduction in tyrosine 
phosphorylation in K562 cells following treat-
ment with the tyrosine kinase inhibitor (TKI) 
imatinib-mesylate, the founder of a class of 
highly effective BCR/ABL inhibitors of clinical 
efficacy [126]. This procedure identified a use-
ful biomarker of drug efficacy and has been 
cross-validated with conventional methods [98]. 
De facto TKIs represent the current state-of-the-
art for the cure of CML [127] and the possibility 
to monitor ex vivo, with minimal sample treat-
ment, the efficacy of TKI treatment in the indi-
vidual patient by microFT-IR can represent a 
step forward for a more efficient and targeted 
personalized medicine. 
 
4. Towards the use of mid-IR spectrum as 
a marker of cancer and anticancer therapy 
follow up 
 
Generally we refer to a cancer biomarker as a 
specific gene or a more or less expressed pro-
tein or protein activity or as some “…omics” pro-
files. Therefore we approach mid-IR analyses in 
search of some specific vibrational components 
with the equivalent significance of a traditional 
cancer biomarker. On the contrary, what the 
mid-IR spectrum of a cell reflects is the overall 
vibrations of cell components and their interac-
tion within the sample. Therefore, specific pro-
tein components, for instance BCR/ABL onco-
protein, cannot be directly measured in the 
spectrum of K562 cells without some labeling 
and/or other forms of pre-treatment in samples 
and in the absence of a calibration method 
[75]. Due to the lack of such specific molecular 
information, many are skeptics about the possi-
bility that the mid-IR absorbance spectrum, 
which snapshots the whole biochemical compo-
Figure 5. The unsupervised recognition of spontaneous 
apoptosis in the spectra of MEG-01 leukemic blasts. a. 
Hierarchical Cluster Analysis (HCA), was applied to several 
spectra of individual MEG-01 blasts that had been ob-
tained by SR microFT-IR absorbance spectroscopy per-
formed at the beamline B22 Infrared Microspectroscopy 
end station of Diamond Light Source (probing area: 15 
µm x 15 µm either in the sample and in the background; 
IR source: Synchrotron Radiation; detector: MCT with a 50 
µm2 detecting area; IR sampling interval: 4000-700 cm-1, 
number of scans: 128; scanner velocity 40 kHz; spectral 
sensitivity 4 cm-1). HCA was performed by a standard 
method and Ward’s algorithm applied to the interval of 
frequencies 1780-1480 cm-1 in the spectra pre-treated 
with vector normalization and second derivative calcu-
lated with the Savitzky-Golay smoothing algorithm on 9 
points. b. The two spectral patterns representative of 
apoptotic (red trace) and G0-G1 viable (blue trace) MEG-
01 cells were obtained by averaging parental spectra 
clustered by HCA in each of the two final groups, respec-
tively. Typical IR signatures of cell apoptosis are the shift 
of amide I and amide II peaks towards lower wavenum-
bers and the increased absorbance at ~1740 cm-1 as-
signed to the C=O in phospholipid. Independent validation 
of IR data was obtained by the analysis of apoptotic 
events carried out in parallel samples by complementary 
techniques (data not shown). 
 
Molecular vibrations in cancer research 
 
 
16                                                                                                                     Am J Cancer Res 2012;2(1):1-21 
sition of a cell and that is sensitive to structural 
changes, can be used as a biomarker of cancer 
or of cancer progression or of anticancer ther-
apy efficacy. With the attempt to move microFT-
IR “from bench top to bedside” new powerful 
algorithm for automatic data analysis and treat-
ment of large data sets have been therefore 
developed allowing the easy interpretation of IR 
data also by non spectroscopists. Examples 
concerning with the reliability in applying mi-
croFT-IR for screening and early diagnosis of 
cancer are cervical cancer [31], exfoliative cytol-
ogy [128], and the analysis of multiple prostate 
biopsies where different cell components within 
a tissue might be identified by qualitative and 
quantitative analysis allowing to be correctly 
classified by objective criteria [57]. 
 
5. Conclusions 
 
The main limitations of microFT-IR spectroscopy 
can be summarized in its relatively low spatial 
resolution limited to the sizes of a cell and a 
certain difficulty to analyze wet samples. Other 
factors are commonly shared with many other 
methods. On the contrary advantages are repre-
sented by the possibility to obtain biochemical 
information on molecular composition and 
structure at the level of single cell within a time-
scale of few seconds-minutes and to perform 
qualitative and quantitative multi-component 
analyses allowing automated pattern recogni-
tion and objective classifications in samples 
with minimal and label-free sample treatment 
(mostly formalin fixation followed by wash in 
water and dehydration). The hope is not only 
that technical improvements will progressively 
increase the number of potential applications of 
microFT-IR to cancer research and clinical diag-
nosis but also that in the next future pre-clinical 
and clinical trials will include sample evaluation 
utilizing this technique in order to obtain data 
necessary to validate the use of microFT-IR 
spectroscopy in a clinical context. In fact, this 
appears to be the most important way to reduce 
the too high level of skepticism of many biolo-
gists and pathologists about an old technology 
that has been designed and improved mainly 
for applications in cancer research and clinical 
diagnosis. 
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